Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 CAD | -2.50% | 0.00% | +34.48% |
Jun. 25 | Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024 | CI |
Jun. 03 | Devonian Health Group Founder Assumes Chair, COO Roles | MT |
Valuation
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 31.2 | 19.18 | 13.2 | 44.91 | 59.01 | 39.73 |
Enterprise Value (EV) 1 | 34.49 | 23.38 | 16.97 | 49.84 | 55.49 | 38.34 |
P/E ratio | -8.33 x | -5.66 x | -2.65 x | -12.6 x | -15.5 x | -8.09 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 9.75 x | 3.23 x | 6.16 x | 30.5 x | 25.6 x | 16.9 x |
EV / Revenue | 10.8 x | 3.94 x | 7.92 x | 33.8 x | 24.1 x | 16.3 x |
EV / EBITDA | -15.7 x | -10.7 x | -5.54 x | -38.5 x | -26.8 x | -9.77 x |
EV / FCF | -32 x | -91.3 x | -21.9 x | -55.9 x | -25.9 x | -15.2 x |
FCF Yield | -3.13% | -1.09% | -4.57% | -1.79% | -3.86% | -6.59% |
Price to Book | 2.25 x | 1.68 x | 1.41 x | 5.96 x | 3.63 x | 2.79 x |
Nbr of stocks (in thousands) | 73,417 | 76,737 | 82,523 | 93,562 | 131,139 | 144,458 |
Reference price 2 | 0.4250 | 0.2500 | 0.1600 | 0.4800 | 0.4500 | 0.2750 |
Announcement Date | 11/28/18 | 11/28/19 | 11/30/20 | 11/26/21 | 11/28/22 | 11/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 3.2 | 5.938 | 2.143 | 1.475 | 2.305 | 2.345 |
EBITDA 1 | -2.197 | -2.177 | -3.062 | -1.296 | -2.07 | -3.925 |
EBIT 1 | -2.837 | -3.19 | -4.085 | -2.306 | -2.913 | -4.324 |
Operating Margin | -88.67% | -53.73% | -190.61% | -156.37% | -126.35% | -184.37% |
Earnings before Tax (EBT) 1 | -3.284 | -3.223 | -4.375 | -3.346 | -3.448 | -4.6 |
Net income 1 | -3.187 | -2.979 | -4.375 | -3.346 | -3.448 | -4.6 |
Net margin | -99.6% | -50.18% | -204.13% | -226.92% | -149.59% | -196.11% |
EPS 2 | -0.0510 | -0.0442 | -0.0604 | -0.0380 | -0.0290 | -0.0340 |
Free Cash Flow 1 | -1.078 | -0.256 | -0.7754 | -0.8922 | -2.144 | -2.527 |
FCF margin | -33.7% | -4.31% | -36.18% | -60.5% | -92.99% | -107.76% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/28/18 | 11/28/19 | 11/30/20 | 11/26/21 | 11/28/22 | 11/28/23 |
Balance Sheet Analysis
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.29 | 4.19 | 3.77 | 4.93 | - | - |
Net Cash position 1 | - | - | - | - | 3.53 | 1.39 |
Leverage (Debt/EBITDA) | -1.497 x | -1.926 x | -1.231 x | -3.805 x | - | - |
Free Cash Flow 1 | -1.08 | -0.26 | -0.78 | -0.89 | -2.14 | -2.53 |
ROE (net income / shareholders' equity) | -30.5% | -26.1% | -43.2% | -39.6% | -29% | -30.1% |
ROA (Net income/ Total Assets) | -11.5% | -11% | -15.1% | -9.21% | -10.1% | -13.3% |
Assets 1 | 27.6 | 27.12 | 28.97 | 36.34 | 34.28 | 34.69 |
Book Value Per Share 2 | 0.1900 | 0.1500 | 0.1100 | 0.0800 | 0.1200 | 0.1000 |
Cash Flow per Share 2 | 0.0100 | 0 | 0.0100 | 0 | 0.0200 | 0.0400 |
Capex | - | - | - | - | 0.07 | - |
Capex / Sales | - | - | - | - | 3.2% | - |
Announcement Date | 11/28/18 | 11/28/19 | 11/30/20 | 11/26/21 | 11/28/22 | 11/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+34.48% | 21.75M | |
+57.48% | 823B | |
-7.18% | 353B | |
+15.37% | 320B | |
+7.45% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.14% | 167B | |
-2.99% | 159B |
- Stock Market
- Equities
- GSD Stock
- Financials Devonian Health Group Inc.